Angiotensin II: from blood pressure to pain control

Affiliations

¹ Danish Pain Research Center, Aarhus University, 8000 Aarhus C, Denmark. Electronic address: finnerup@ki.au.dk.
² Danish Pain Research Center, Aarhus University, 8000 Aarhus C, Denmark.

Comment

Nanna Brix Finnerup et al. Lancet. 2014.

. 2014 May 10;383(9929):1613-1614.

doi: 10.1016/S0140-6736(13)62638-0. Epub 2014 Feb 5.

¹ Danish Pain Research Center, Aarhus University, 8000 Aarhus C, Denmark. Electronic address: finnerup@ki.au.dk.
² Danish Pain Research Center, Aarhus University, 8000 Aarhus C, Denmark.

No abstract available

Comment on

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Rice ASC, Dworkin RH, McCarthy TD, Anand P, Bountra C, McCloud PI, Hill J, Cutter G, Kitson G, Desem N, Raff M; EMA401-003 study group. Rice ASC, et al. Lancet. 2014 May 10;383(9929):1637-1647. doi: 10.1016/S0140-6736(13)62337-5. Epub 2014 Feb 5. Lancet. 2014. PMID: 24507377 Clinical Trial.